Portal de Periódicos da CAPES

Transfemoral access when superior venous approach is not feasible equals overall success of permanent pacemaker implantation. Ten‐year series

2017; Wiley; Volume: 40; Issue: 6 Linguagem: Inglês

10.1111/pace.13082

1540-8159

Juan J. García Guerrero, Joaquin Castaneda, Manuel Doblado Calatrava, Ángel Redondo Méndez, Manuel Lázaro Medrano, Antonio Merchán Herrera,

Atrial Fibrillation Management and Outcomes

Abstract Background When permanent pacemaker implantation is not possible or advisable via superior venous access (i.e., axillary or subclavian veins), safe and feasible surgical alternatives are required. The femoral approach is relatively unknown and seldom studied. This single‐center study analyzed 10‐year outcomes of a femoral implantation approach. Methods Data about the implantation procedure (indication, approach, lead and pacemaker models, complications), patient characteristics (age, sex, medications, comorbidities), and follow‐up were analyzed for all permanent pacemaker implantations using the femoral approach between June 2001 and June 2011. Results A permanent pacemaker was implanted with the femoral approach in 50 patients (mean age, 76 years [range: 45–96], 31 [61%] men). The most frequent indication was atrioventricular block, associated with sinus rhythm in 30 patients and with atrial fibrillation in eight patients. Overall, 20 patients (40%) were treated with oral anticoagulants postimplantation. Mean implantation time was 64 minutes (range: 20–210) and mean fluoroscopy time was 6.7 minutes (range: 0.2–50). Minimum follow‐up window was 1 year (June 2012), with a mean of 50 months [range: 1–113]). No deaths, septic episodes, or severe complications were associated with the procedure, acute or long‐term. Follow‐up data were available for 46 patients, of who 21 (46%) died during follow‐up (mean age, 87 years [range: 73–101]). No cause of death was associated with the femoral technique. Conclusion Permanent pacemaker implantation through femoral access is not difficult for an experienced implant surgeon. Outcomes were comparable to systems implanted by superior venous approach, and no severe complications were observed at 10‐year follow‐up.